BiotechTube

Steroids + Basiliximab + Tacrolimus + Enteric-coated Mycophenolic acid (EC-MPA)

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Liver Cirrhosis

Conditions

Liver Cirrhosis, Liver Transplant Disorder

Trial Timeline

Feb 1, 2006 โ†’ Jun 1, 2008

NCT ID
NCT00296244

About Steroids + Basiliximab + Tacrolimus + Enteric-coated Mycophenolic acid (EC-MPA)

Steroids + Basiliximab + Tacrolimus + Enteric-coated Mycophenolic acid (EC-MPA) is a approved stage product being developed by Novartis for Liver Cirrhosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00296244. Target conditions include Liver Cirrhosis, Liver Transplant Disorder.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00296244ApprovedCompleted

Competing Products

20 competing products in Liver Cirrhosis

See all competitors
ProductCompanyStageHype Score
LanifibranorInventivaPhase 2
47
GODEX + PlaceboCelltrionPhase 3
77
peginterferon alfa-2a 180ฮผg + peginterferon alfa-2a 90ฮผg + ribavirinChugai PharmaceuticalPhase 3
77
exatecan mesylateDaiichi SankyoPhase 2
52
TacrolimusAstellas PharmaPre-clinical
23
ATG (Fresenius Biotech)Astellas PharmaPhase 2
52
Advagraf + Prograf + PrografAstellas PharmaApproved
85
Prograf + AdvagrafAstellas PharmaApproved
85
ADVAGRAFยฎAstellas PharmaApproved
85
Prograf + MR4Astellas PharmaPhase 3
77
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 3
77
Prograf-XL + Prograf + MMFAstellas PharmaPhase 3
77
micafungin + fluconazole + liposomal amphotericin B + caspofunginAstellas PharmaPhase 3
77
Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
85
FK506E (modified release tacrolimus) + Prograf (tacrolimus)Astellas PharmaPhase 3
77
FK778Astellas PharmaPhase 2
52
Tacrolimus modified-release + PrografAstellas PharmaPhase 3
77
Advagraf + PrografAstellas PharmaApproved
85

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85